Nursing Perspectives on Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma
Guest Editor
Sandra E. Kurtin, RN, MS, AOCN®, ANP-C
The supplement and associated publication costs were funded by Onyx Pharmaceuticals, Inc. Fishawack Communications, Inc., provided medical writing and editorial assistance, supported by Onyx Pharmaceuticals.
Review ArticleSandra E. Kurtin, RN, MS, AOCN®, ANP-CRead More
Prescriber's CornerJ. Michael Vozniak, PharmD, BCOPRead More
Review ArticleLaura McBride, RN, BSN, OCN®, CCRP, and Christine O. Samuel, RN, BSN, OCN®, CCRPRead More
Grand RoundsSandra E. Kurtin, RN, MS, AOCN®, ANP-CRead More
Review ArticleDonna Catamero, ANP-BC, OCN®, CCRC, and Charise Gleason, MSN, ANP, AOCNP®Read More